 CUPERTINO, Calif., Sept. 02, 2021 GLOBE NEWSWIRE -- Reviva Pharmaceuticals Holdings, Inc. NASDAQ: RVPH Reviva or the Company, a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system CNS, cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright 23rd Annual Global Investment Conference as well as participate in one-on-one meetings with investors. The Conference will be held virtually with all participants joining remotely from September 13th - 15th. 